Berlin-based genomics and proteomics services company ImaGenes has been named a Roche NimbleGen certified service provider for comparative genomic hybridization.
ImaGenes is the first service provider in Europe certified to offer CGH on Roche's microarray platform. The company was certified by Roche NimbleGen for ChIP-chip in 2009 and DNA methylation analysis in February.